Publisher: Consultant Live

Phase 2 Trial of ILYX-002 Shows Improved Conjunctival Staining in DED, with Penny Asbell, MD, MBA

Published by Consultant Live
In the Media Icon

Investigative topical immunomodulator ILYX-002 has proven its efficacy in treating moderate-to-severe dry eye disease (DED) by achieving its primary endpoint of total conjunctival staining in the recent ILYX-002-201 phase 2 trial.

Discussing Dose Flexibility in Adult Atopic Dermatitis, with Tejesh Patel, MD

Published by Consultant Live
In the Media Icon

At the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, Tennessee, the HCPLive editorial team sat down with Tejesh Patel, MD/MBBS, about his portion of the session at RAD titled ‘Dose Flexibility in Adult Atopic Dermatitis.’